Submissions from 2023
Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation., Marios Dimitriou, Teresa Mortera-Blanco, Magnus Tobiasson, Stefania Mazzi, Madeleine Lehander, Kari Högstrand, Mohsen Karimi, Gunilla Walldin, Monika Jansson, Sofie Vonlanthen, Per Ljungman, Saskia M C Langemeijer, Tetsuichi Yoshizato, Eva S Hellstrom-Lindberg, Petter S Woll, and Sten Eirik W Jacobsen
MDR1-EXPRESSING CD4, Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, and Christine Ménétrier-Caux
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group., Antoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, Wesley Yip, Robert G Uzzo, Vitaly Margulis, Matteo Ferro, Ottavio De Cobelli, Zhenjie Wu, Giuseppe Simone, Riccardo Mastroianni, Koon H Rha, Daniel D Eun, Adam C Reese, James R Porter, Ithaar Derweesh, Reza Mehrazin, Giuseppe Rosiello, Riccardo Tellini, Marcus Jamil, Alexander Kenigsberg, Jason M Farrow, William P Schrock, Giovanni Cacciamani, Abhishek Srivastava, Amit S Bhattu, Alexandre Mottrie, Mark L Gonzalgo, Chandru P Sundaram, Firas Abdollah, Andrea Minervini, Riccardo Autorino, and Hooman Djaladat
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study., Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, and Richard L Schilsky
Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)., Anthony B. El-Khoueiry, K A Margolin, Rachel E Sanborn, and See all authors in comments
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial., Espen B Ellingsen, Steven O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S Kristedja, Mohammed Milhem, and Yousef Zakharia
Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer., Miquel Ensenyat-Mendez, Javier I J Orozco, Pere Llinàs-Arias, Sandra Íñiguez-Muñoz, Jennifer L Baker, Matthew P Salomon, Mercè Martí, Maggie L DiNome, Javier Cortés, and Diego M Marzese
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer., Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope, Fernanda Musa, Robert Mannel, Mark S Shahin, Guilherme H Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A Leath, Lilian T Gien, Emily M Hinchcliff, Shashikant B Lele, Lisa M Landrum, Floor Backes, Roisin E O'Cearbhaill, Tareq Al Baghdadi, Emily K Hill, Premal H Thaker, Veena S John, Stephen Welch, Amanda N Fader, Matthew A Powell, and Carol Aghajanian
Regarding: "Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma," by Faries, Mark et al., Richard Essner and Jennifer Keller
Objective assessment of intraoperative skills for robot-assisted partial nephrectomy (RAPN)., Rui Farinha, Alberto Breda, James Porter, Alexandre Mottrie, Ben Van Cleynenbreugel, Jozef Vander Sloten, Angelo Mottaran, and Anthony G Gallagher
National Cancer Institute Imaging Data Commons: Toward Transparency, Reproducibility, and Scalability in Imaging Artificial Intelligence., Andrey Fedorov, William J R Longabaugh, David Pot, David A Clunie, Steven D Pieper, David L Gibbs, Christopher Bridge, Markus D Herrmann, André Homeyer, Rob Lewis, Hugo J W L Aerts, Deepa Krishnaswamy, Vamsi Krishna Thiriveedhi, Cosmin Ciausu, Daniela P Schacherer, Dennis Bontempi, Todd Pihl, Ulrike Wagner, Keyvan Farahani, Erika Kim, and Ron Kikinis
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial., E Felip, N Altorki, C Zhou, Eric Vallieres, A Martínez-Martí, A Rittmeyer, A Chella, M Reck, O Goloborodko, M Huang, R Belleli, V McNally, M K Srivastava, E Bennett, B J Gitlitz, and H A Wakelee
NKG2A expression on tumor reactive CD8 T cells is induced by IL-12, O Fesneau, J Huang, T Duhen, and See full list of authors in comments
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma., Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff, Natalie A LaFranzo, Zachary S Bradley, Joey Babbitt, William H Westra, Raymond Hsu, Lincoln Nadauld, Howard Mcleod, Sean D Firth, Brittany Sharp, Josh Fuller, Vera Vavinskaya, Leisa Sutton, Ida Deichaite, Samuel D Bailey, Vlad C Sandulache, Matthew J Rendo, Orlan K Macdonald, Karim Welaya, James L Wade, Andrew W Pippas, Jennifer Slim, Bruce Bank, Steven J Saccaro, Xingwei Sui, Adil Akhtar, Savitha Balaraman, Steven E Kossman, Scott A Sonnier, Todd D Shenkenberg, Warren L Alexander, Katherine A Price, Charles L Bane, Jessica Ley, David N Messina, Jarret I Glasscock, Ezra E W Cohen, Douglas R Adkins, and Eric J Duncavage
Abstract 4876: A systems pharmacology approach to discover synergistic targeted therapy combinations, Cameron T. Flower, Chunmei Liu, James R Heath, Wei Wei, and Forest M. White
American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations., Nauzer Forbes, Sherif E Elhanafi, Mohammad A Al-Haddad, Nirav C Thosani, Peter V Draganov, Mohamed O Othman, Eugene P Ceppa, Vivek Kaul, Michael M Feely, Ilyas Sahin, James L Buxbaum, Audrey H Calderwood, Jean M Chalhoub, Nayantara Coelho-Prabhu, Madhav Desai, Larissa L Fujii-Lau, Divyanshoo R Kohli, Richard S Kwon, Jorge D Machicado, Neil B Marya, Swati Pawa, Wenly Ruan, Sunil G Sheth, Andrew C Storm, Nikhil R Thiruvengadam, and Bashar J Qumseya
Immune Interception of Pre-Malignancy, B Fox
Cancer Vaccines, Bernard Fox
Cancer Vaccine Strategies, Bernard Fox
Cellular Therapy, Bernard Fox
Developing Combination Immunotherapy that Includes Cancer Vaccines, Bernard Fox
Developing Combination Immunotherapy with Cancer Vaccines, Bernard Fox
Developing Combination Immunotherapy with Cancer Vaccines, Bernard Fox
Immunotherapy of Cancer, Bernard Fox
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies., Bernard A Fox, Walter J Urba, Shawn M Jensen, David B Page, Brendan D Curti, Rachel E Sanborn, and Rom S Leidner
Abstract 901: Monitoring of Neoantigens and Adoptively Transferred Personalized NeoTCR T Cell Populations in the Tumor and PBMCs of Patients with Solid Tumors, Susan Foy, Cliff Wang, Benjamin Yuen, Sara Said, Boi Quach, Jonathan Hoover, Saparya Nayak, Theresa Hunter, Zheng Pan, Chad Smith, Tyler Borrman, Eric Stawiski, Alphonsus H.C. Ng, Yue Lu, James R Heath, and Stefanie Mandl
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion., Yasunari Fukuda, Sun-Hee Kim, Matias A Bustos, Sung-Nam Cho, Jason Roszik, Jared K Burks, Hong Kim, Dave S B Hoon, Elizabeth A Grimm, and Suhendan Ekmekcioglu
Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment., Satoru Furuhashi, Matias A Bustos, Shodai Mizuno, Suyeon Ryu, Yalda Naeini, Anton J Bilchik, and Dave SB Hoon
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study, Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Robot-assisted retroperitoneal lymph node dissection: a systematic review of perioperative outcomes., Harshit Garg, Ahmed M Mansour, Sarah P Psutka, Simon P Kim, James Porter, Christine S Gaspard, Furkan Dursun, Deepak K Pruthi, Hanzhang Wang, and Dharam Kaushik
Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies, B Garmezy, Brendan Curti, and See full list of authors in comments
Feasibility of intraoperative injection of radioactive tracer and blue dye for sentinel lymph node biopsy in vulvar cancer., Alison A Garrett, Jason Ricciuti, Susan M Lang, Mary E Burriss, Margaret Flanigan, Emily O'Brien, Casey Hay, Jamie Lesnock, Jessica L Berger, and Sarah E Taylor
13. Long-term efficacy, safety and predictors of response to amivantamab among patients with post-platinum EGFR exon 20 insert (Ex20ins)-mutated advanced non-small cell lung cancer (aNSCLC) — CHRYSALIS (NCT02609776), P Garrido, Rachel E Sanborn, and See full list of authors in comments
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study., Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros, Renata R Urban, Heidi J Gray, Barbara A Goff, Chirag A Shah, Nikki L Neubauer, James Y Dai, Janos L Tanyi, and John B Liao
Precise tumor & patient selection for CDR404: A bispecific & bivalent MAGE-A4 T cell engager, G Giacomazzi, Rom Leidner, and See full list of authors in comments
The presence of targetable mutations in metastatic non-small cell lung cancer patients with malignant pleural disease is not associated with improved survival The American Thoracic Society Washington, DC, CR Gilbert, Candice L. Wilshire, and See all authors in comments
Mammogram perceptions, communication, and gaps in care among individuals with non-English language preference in Oregon and Washington states., Monique Gill, Hannah Cohen-Cline, Megan Holtorf, and Keri Vartanian
Risk factors for venous thromboembolism (VTE) among patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) receiving amivantamab plus lazertinib versus either agent alone, N Girard, Rachel Sanborn, and See all authors in comments
Characterization of Lymph Node Tumor Burden in Node-Positive Prostate Cancer Patients after Robotic-Assisted Radical Prostatectomy with Extended Pelvic Lymph Node Dissection., Josh Gottlieb, Shu-Ching Chang, Jane Choe, Gary Grunkemeier, Douglas Hanes, David L Krasne, Dave S B Hoon, and Timothy G Wilson
Predictors of Intraoperative Difficulty and Postoperative Examination Abnormalities in 164 Orbital Operations., Akshay Govind, Shaban Demirel, Kristin Lee, Melissa Amundson, Richard Bryan Bell, and Eric Dierks
Pap smear recommendations in older women, does the data support stopping?, Emma Grabinski and Rebecca Dunsmoor-Su
“Impact of Her2 Low on Survival in Patients Treated with Standard Therapies in Advanced Breast Cancer”, SL Graff, Bansal Rani, Adeyelu Tolulope, Elliott Andrew, Walker Phillip, MA Bustos, Rodriguez Estelamari, and See full list of authors in comments
Newly Approved and Emerging Agents in HER2-Positive Metastatic Breast Cancer., Stephanie L Graff, Fengting Yan, and Yara Abdou
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing., Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger, Robert L Diaz, Hallie A Swan, Danielle Peretti, Maddy Pollastro, Trevor Ainge, Katannya Kapeli, Shalini Pereira, Astrid L Margossian, Kalyan Banda, Barbara A Goff, Elizabeth M Swisher, Brady Bernard, Christopher J Kemp, and Carla Grandori
Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays., Sarah R Greytak, Kelly B Engel, Dave S B Hoon, Kevin M Elias, Christina M Lockwood, Ping Guan, and Helen M Moore
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck Pathology., Ruta Gupta, Munita Bal, Justin A Bishop, Keith D Hunter, Kelly Magliocca, Raja R Seethala, Lester D R Thompson, Ilan Weinreb, Peter Angelos, Beth Beadle, R Bryan Bell, Jonathan R Clark, Robert Ferris, Shao Hui Huang, D Neil Hayes, Rahul Ladwa, Jean Yang, Nicole A Cipriani, Brenda L Nelson, Peter M Sadow, and James S Lewis
A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors., Ankit Halder, Deeptarup Biswas, Aparna Chauhan, Adrita Saha, Shreeman Auromahima, Deeksha Yadav, Mehar Un Nissa, Gayatri Iyer, Shashwati Parihari, Gautam Sharma, Sridhar Epari, Prakash Shetty, Aliasgar Moiyadi, Graham Roy Ball, and Sanjeeva Srivastava
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy., Thorvardur R Halfdanarson, Nadine Mallak, Scott Paulson, Chandrikha Chandrasekharan, Mona Natwa, Ayse Tuba Kendi, and Hagen F Kennecke
Sentinel lymphatic mapping for gynecologic malignancies., Anjali Y Hari and Krishnansu S Tewari
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma., Jessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, Jean-Francois Baurain, Max Schlaak, Marcus O Butler, Ryan J Sullivan, Reinhard Dummer, John M Kirkwood, Marlana Orloff, Joseph J Sacco, Sebastian Ochsenreither, Anthony M Joshua, Lauris Gastaud, Brendan Curti, Josep M Piulats, April K S Salama, Alexander N Shoushtari, Lev Demidov, Mohammed Milhem, Bartosz Chmielowski, Kevin B Kim, Richard D Carvajal, Omid Hamid, Laura Collins, Koustubh Ranade, Chris Holland, Constance Pfeiffer, and Paul Nathan
An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer., James R Heath, Daniel Chen, Jingyi Xie, Jongchan Choi, Rachel H Ng, Rongyu Zhang, Sarah Li, Rick Edmark, Hong Zheng, Benjamin Solomon, Katie Campbell, Egmidio Medina, Antoni Ribas, Purvesh Khatri, Lewis Lanier, Philip Mease, Jason D Goldman, and Yapeng Su
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer., Thomas J Herzog, Sandro Pignata, Sharad A Ghamande, Maria-Jesús Rubio, Keiichi Fujiwara, Christof Vulsteke, Deborah K Armstrong, Jalid Sehouli, Robert L Coleman, Hani Gabra, Giovanni Scambia, Bradley J Monk, José A Arranz, Kimio Ushijima, Rabbie Hanna, Claudio Zamagni, Robert M Wenham, Antionio González-Martín, Brian Slomovitz, Yan Jia, Lisa Ramsay, Krishnansu S Tewari, Susan C Weil, and Ignace B Vergote
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants., Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, Mathieu Gigoux, David Schröder, Andrew Chow, Jacob M Ricca, Billel Gasmi, Olivier De Henau, Levi Mark B Mangarin, Yanyun Li, Linda Hamadene, Anne-Laure Flamar, Hyejin Choi, Czrina A Cortez, Cailian Liu, Aliya Holland, Sara Schad, Isabell Schulze, Allison Betof Warner, Travis J Hollmann, Arshi Arora, Katherine S Panageas, Gabrielle A Rizzuto, Rebekka Duhen, Andrew D Weinberg, Christine N Spencer, David Ng, Xue-Yan He, Jean Albrengues, David Redmond, Mikala Egeblad, Jedd D Wolchok, and Taha Merghoub
T cell immunotherapies recruit and activate neutrophils to eliminate tumor antigen escape variants, D Hirschorn, AD Weinberg, and See full list of authors in comments
Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study, AL Ho, Rom Leidner, and See full list of authors in comments
Monitoring 1q21.3 amplification in circulating tumor DNA from metastatic melanoma patients receiving immune checkpoint inhibitor therapies, DSB Hoon, SY Lin, Y Kobayashi, X Zhang, Q Yu, S O’Day, and MA Bustos
“UBQLN4 triggers MRE11a and STING proteasomal degradation during cisplatin-induced DNA damage response in solid tumors, DSB Hoon, Y Shiloh, T Murakami, Y Kobayashi, R Jachimowicz, and MA Bustos
Mouse Models for Sarcoma Research: NEAT1 Promotes Sarcoma Metastasis, J Huang
Organotypic Models for Functional Drug Testing of Human Cancers., Yu Ling Huang, Lindsay K Dickerson, Heidi Kenerson, Xiuyun Jiang, Venu Pillarisetty, Qiang Tian, Leroy Hood, Taranjit S Gujral, and Raymond S Yeung
Organotypic Models for Functional Drug Testing of Human Cancers, Yu Ling Huang, Lindsay K. Dickerson, Heidi Kenerson, Xiuyun Jiang, Venu Pillarisetty, Qiang Tian, Leroy Hood, Taranjit S. Gujral, and Raymond S. Yeung
Pan-cancer associations of B7-H3 (CD276) transcriptioinal expression across human malignancies. ASCO, Abst:2624, 6/2023., J Hwang, Dave Hoon, and See full list of authors in comments
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases., Gino K In, Jennifer R Ribeiro, Jun Yin, Joanne Xiu, Matias A Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K S Salama, Soo J Park, Justin C Moser, Sourat Darabi, Evidio Domingo-Musibay, Maria L Ascierto, Kim Margolin, Jose Lutzky, Geoffrey T Gibney, Michael B Atkins, Benjamin Izar, Dave Hoon, and Ari M VanderWalde
Detection of KRAS G12D/G12V neoepitopes expressed by cancer cell lines using LC-MS/MS, N Iwamoto, Will Redmond, Brian Piening, Bernard Fox, Eric Tran, and See full list of authors in comments
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway., Sivan Izraely, Shlomit Ben-Menachem, Sapir Malka, Orit Sagi-Assif, Matias A Bustos, Orit Adir, Tsipi Meshel, Maharrish Chelladurai, Suyeon Ryu, Romela Irene Ramos, Metsada Pasmanik-Chor, Dave S B Hoon, and Isaac P Witz
ASO Author Reflections: Considerations for the Contralateral Breast in Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson and Janie Grumley
A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson, Janelle-Cheri Millen, Javier I Orozco, Stacey Stern, Crystal E Fancher, and Janie Grumley
ASO Visual Abstract: A Look at the Other Side-High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures of Patients Undergoing Oncoplastic Breast-Conserving Surgery., Katherine M Jackson, Janelle-Cheri Millen, Javier I Orozco, Stacey Stern, Crystal E Fancher, and Janie Grumley
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors., Joseph M Jacob, Solomon L Woldu, Jennifer Linehan, Craig Labbate, Kyle M Rose, Wade J Sexton, Isamu Tachibana, Hristos Kaimakliotis, Alan Nieder, Marc A Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus L Quek, Brett Johnson, Michael O'Donnell, Brian H Eisner, Adam S Feldman, Katie S Murray, Surena F Matin, Yair Lotan, and Rian J Dickstein
Diagnostic Performance and Safety of, Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Reply by Authors., Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT), Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, Barry A Siegel, Przemyslaw W Twardowski, Daniel Saltzstein, Mark T Fleming, Albert Chau, Phillip Davis, Brian F Chapin, and David M Schuster
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors., Antonio Jimeno, Joaquina Baranda, Wade T Iams, Jong Chul Park, Monica Mita, Michael S Gordon, Matthew Taylor, Neesha Dhani, Alexis D Leal, Prakash Neupane, Cathy Eng, Oladapo Yeku, Alain Mita, Justin C Moser, Marcus Butler, Scott M Loughhead, Julia Jennings, Nathan R Miselis, Rui-Ru Ji, Nitya Nair, Martin Kornacker, Ricardo F Zwirtes, Howard Bernstein, and Armon Sharei
SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16 tumors treated with cell-based vaccine, SQZ-PBMC-HPV, A Jimeno, Matthew Taylor, and See full list of authors in comments
Synergism in actions of HBV with aflatoxin in cancer development., Joshua Jin, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network., Sean J Judge, Tara Ghalambor, Michael J Cavnar, Michael E Lidsky, Ryan P Merkow, May Cho, Ismael Dominguez-Rosado, Paul J Karanicolas, Skye C Mayo, Flavio G Rocha, Ryan C Fields, Reema A Patel, Hagen F Kennecke, Bas Groot Koerkamp, Adam C Yopp, Henrik Petrowsky, Devalingham Mahalingam, Nancy Kemeny, Michael D'Angelica, and Sepideh Gholami
ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy—An International Survey of the HAI Consortium Research Network, Sean J. Judge, H Kennecke, and See all authors in comments
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma., Hristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, Craig Labbate, Joseph Jacob, Katie Murray, Kyle Rose, Wade Sexton, Rian Dickstein, Jennifer M Linehan, Alan Nieder, Marc Bjurlin, Mitchell Humphreys, Saum Ghodoussipor, Marcus Quek, Michael O'Donnell, Brian H Eisner, Surena F Matin, Yair Lotan, and Adam S Feldman
Mapping inter- and intra-tumor heterogeneity in Ductal Carcinoma in situ and invasive breast cancer using integrative multi-omic profiling, H Kaplan, Carlo Bifulco, Brian Piening, and See full list of authors in comments
Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment., Henry G Kaplan, Somasundaram Subramaniam, Eric Vallières, and Todd Barnett
Hormone Receptor-Positive Breast Cancer Sensitive to Pembrolizumab: Evidence of the Pathogenicity of the MLH1 Variant 1835del3., Henry G Kaplan, Jeffrey R Whiteaker, Brianna Nelson, Richard G Ivey, Travis D Lorentzen, Uliana Voytovich, Lei Zhao, David J Corwin, Robert Resta, and Amanda G Paulovich
Treatment with a novel hexavalent OX40 agonist remodels the tumor microenvironment to favor anti-tumor immunity in mice, M Kasiewicz, Will Redmond, and See full list of authors in comments
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy., Saro Kasparian, Oren Wei, Ni-Chun Tsai, Joycelynne Palmer, Sumanta Pal, Yung Lyou, and Tanya Dorff
The role of dendritic cells in radiation-induced immune responses., Aanchal Preet Kaur, Alejandro F Alice, Marka R Crittenden, and Michael J. Gough
Ex vivo analysis of radiation effects on tumor infiltrating immune cells using tumor explants., Aanchal Preet Kaur, Gwen Kramer, Marka R Crittenden, and Michael Gough
Abstract 6410: Deciphering the role of MyD88 signaling pathway in regulating type I IFN-mediated responses to radiation therapy in solid tumors, Aanchal Preet Kaur, Terry R. Medler, Tiffany C. Blair, Alejandro F. Alice, Megan R. Ball, Alexa K Dowdell, Brian D. Piening, Marka R Crittenden, and Michael J. Gough
3D co-culture models demonstrate radiation-mediated activation of tumor-associated macrophages, AP Kaur, Marka R Crittenden, Michael J. Gough, and See all authors in comments
Integrative omic profiling and analyses in two pig heart to human xenotransplants, B Keating, Brian Piening, and See full list of authors in comments
Insufficient Reporting of Race and Ethnicity in Breast Cancer Clinical Trials., Grace Keegan, Angelena Crown, Charles DiMaggio, and Kathie-Ann Joseph
Diversity, Equity, and Inclusion in Clinical Trials., Grace Keegan, Angelena Crown, and Kathie-Ann Joseph
Correction: Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma: The Role of the First Postoperative Ultrasound., Jennifer Keller, Stacey Stern, Shu-Ching Chang, Rebecca Marcus, Jessica Weiss, Sean Nassoiy, Wade Christopher, Trevan Fischer, and Richard Essner
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer., Hagen F Kennecke, Rebecca Auer, May Cho, N Arvind Dasari, Cynthia Davies-Venn, Cathy Eng, Jennifer Dorth, Julio Garcia-Aguilar, Manju George, Karyn A Goodman, Lillian Kreppel, Joshua E Meyer, Jose Monzon, Leonard Saltz, Deborah Schrag, J Joshua Smith, Jason A Zell, Prajnan Das, and National Cancer Institute Rectal-Anal Task Force
Pulmonary Open, Robotic and Thoracoscopic Lobectomy (PORTaL) Study: Survival Analysis of 6,646 Cases., Michael S Kent, Matthew G Hartwig, Eric Vallières, Abbas E Abbas, Robert J Cerfolio, Mark R Dylewski, Thomas Fabian, Luis J Herrera, Kimble G Jett, Richard S Lazzaro, Bryan Meyers, Rishindra M Reddy, Michael F Reed, David C Rice, Patrick Ross, Inderpal S Sarkaria, Lana Y Schumacher, Lawrence N Spier, William B Tisol, Dennis A Wigle, and Michael Zervos
